Tetrabenazine tablets bulk supplier for pharma manufacturers

Tetrabenazine Tablets 25 mg, 50 mg, 75 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 25 mg, 50 mg, 75 mg

Reference Brands: Xenazine(US)

Tetrabenazine is a vesicular monoamine transporter 2 (VMAT2) inhibitor that depletes dopamine, serotonin, and norepinephrine in nerve terminals. It effectively reduces hyperkinetic movements like chorea in Huntington’s disease, supporting symptom control, improving motor function, and enhancing quality of life in movement disorder patients worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Tetrabenazine tablets, marketed as Xenazine, are approved in the US by the FDA and in the EU via EMA for treating hyperkinetic movement disorders such as Huntington’s disease chorea. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data to ensure safety and efficacy, while the EMA ensures regional compliance with safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper regional adherence supports timely approval, safe use, and worldwide availability, helping improve quality of life for patients with movement disorders.

Tetrabenazine Tablets — third party manufacturing & bulk supply

Tetrabenazine Tablets 25 mg, 50 mg, 75 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Tetrabenazine Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Tetrabenazine Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Tetrabenazine Tablets →

Back to Listing

Frequently Asked Questions

Tetrabenazine is used for the treatment of chorea associated with Huntington’s disease. It helps reduce involuntary, irregular, and jerky movements by decreasing excessive dopamine activity in the brain. It may also be used off-label for other hyperkinetic movement disorders under specialist supervision.

Tetrabenazine is a synthetic small-molecule compound developed to reversibly inhibit vesicular monoamine transporter type 2 (VMAT2). This action reduces the storage and release of monoamines such as dopamine, serotonin, and norepinephrine in nerve terminals.

Tetrabenazine is marketed under trade names such as Xenazine and Nitoman.

Xenazine was originally developed by Prestwick Pharmaceuticals and later marketed by Lundbeck. Generic versions of tetrabenazine are manufactured by multiple pharmaceutical companies worldwide.

The complete generic name is tetrabenazine.

The brand names of tetrabenazine include Xenazine and Nitoman, along with various generic brand names depending on the country and manufacturer.

Tetrabenazine is manufactured in multiple countries, including the USA, EU nations, India, and other regulated pharmaceutical markets, depending on the brand owner and generic manufacturer.